ArticleTherapeutic advances in medical oncology2025

Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial.

Radka Lordick Obermannova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.